BSF Enterprise Plc Stock

Equities

BSFA

GB00BHNBDQ51

Pharmaceuticals

Market Closed - London S.E. 11:35:11 2024-04-26 EDT 5-day change 1st Jan Change
5.25 GBX +10.53% Intraday chart for BSF Enterprise Plc +5.00% -48.78%
Sales 2022 - Sales 2023 0.01 0.02 Capitalization 10.59M 14.48M
Net income 2022 - 0 Net income 2023 -1M -1.37M EV / Sales 2022 -
Net cash position 2022 830K 1.13M Net cash position 2023 2.16M 2.96M EV / Sales 2023 651,360,609 x
P/E ratio 2022
-2.79 x
P/E ratio 2023
-6.46 x
Employees 12
Yield 2022 *
-
Yield 2023
-
Free-Float 45.38%
More Fundamentals * Assessed data
Dynamic Chart
1 day+10.53%
1 week+5.00%
Current month-11.02%
1 month-16.00%
3 months-54.35%
6 months-32.26%
Current year-48.78%
More quotes
1 week
4.50
Extreme 4.5
5.50
1 month
4.50
Extreme 4.5
6.74
Current year
4.50
Extreme 4.5
12.45
1 year
4.50
Extreme 4.5
16.90
3 years
3.00
Extreme 3
23.88
5 years
3.00
Extreme 3
23.88
10 years
3.00
Extreme 3
23.88
More quotes
Managers TitleAgeSince
Founder 67 18-09-04
Chief Executive Officer 52 -
Director of Finance/CFO 61 22-06-05
Members of the board TitleAgeSince
Founder 56 18-09-04
Founder 67 18-09-04
Director/Board Member 58 21-08-04
More insiders
Date Price Change Volume
24-04-26 5.25 +10.53% 1,388,523
24-04-25 4.75 -5.00% 212,134
24-04-24 5 0.00% 441,610
24-04-23 5 0.00% 101,100
24-04-22 5 0.00% 193,981

Delayed Quote London S.E., April 26, 2024 at 11:35 am

More quotes
BSF Enterprise PLC is a United Kingdom-based biotechnology company. The Company is focused on developing biotechnological solutions using cell-based tissue engineering to help generate cultured meat, lab-grown leather, as well as human corneas, collagen growth and skin substitutes. The Company operates through its wholly owned subsidiary, 3D Bio-Tissues Limited (3DBT), which is a clinical and cellular agriculture company engaged in producing human corneas that could help restore vision to millions of people. 3DBT has three strands of three intellectual property (IP) each with a different sector focus development and revenue timeline. 3DBT’s City-mix is an animal-free cell growth agent for culturing skin, muscle and fat cells which are used for lab-grown meat and leather production. 3DBT’s Lipopeptide Etsyl actively increases collagen production in human skin cells which can be used in cosmetic and skin care products.
More about the company